查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
粘膜下注射劑的全球市場:分析、歷史、預測 (2017年～2028年)
市場調查報告書
商品編碼
1104946

粘膜下注射劑的全球市場:分析、歷史、預測 (2017年～2028年)

Global Submucosal Injection Agent Market Report, History and Forecast 2017-2028
出版日期: | 出版商: QYResearch | 英文 90 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

由於COVID-19大流行，粘膜下注射劑的全球市場規模2021年價值9,535萬美元，預計2028年調整後規模為1億5,976萬美元，預測期間 (2022年～2028年) 的年複合成長率預測為7.65％。

目錄

第1章 粘膜下注射劑:市場概要

  • 粘膜下注射劑:產品概要
  • 各種類的市場區隔
    • 注射器型
    • 安瓿型
  • 各種類的市場規模
    • 市場規模概要:各類型 (2017年～2028年)
    • 過去的市場規模:各類型 (2017年～2022年)
    • 市場規模的預測:各類型 (2023年～2028年)
  • 主要地區的市場規模:各類型
    • 北美的粘膜下注射劑的銷售:各類型 (2017年～2022年)
    • 歐洲的粘膜下注射劑的銷售:各類型 (2017年～2022年)
    • 亞太地區的粘膜下注射劑的銷售:各類型 (2017年～2022年)
    • 南美的粘膜下注射劑的銷售:各類型 (2017年～2022年)
    • 中東、非洲的粘膜下注射劑的銷售:各類型 (2017年～2022年)

第2章 粘膜下注射劑:各企業的市場競爭

  • 全球粘膜下注射劑的主要企業的銷售 (2020年～2022年)
  • 全球粘膜下注射劑的主要企業的收益 (2020年～2022年)
  • 全球粘膜下注射劑的主要企業的價格 (2020年～2022年)
  • 全球粘膜下注射劑的主要製造商的製造地、銷售區域
  • 粘膜下注射劑市場競爭情形和趨勢
  • 全球主要製造商:企業的各類型 (第一級，第二級，第三級) (各收益，2021年)
  • 主要製造商的主要產品

第3章 粘膜下注射劑:各地區的現狀與展望

  • 全球粘膜下注射劑的市場規模、年複合成長率:各地區 (2017年、2021年、2028年)
  • 過去的市場規模:各地區
  • 市場規模的預測:各地區

第4章 粘膜下注射劑:各用途

  • 各用途的市場規模
    • 市場規模概要:各用途 (2017年～2028年)
    • 過去的市場規模:各用途 (2017年～2022年)
    • 市場規模的預測:各用途 (2023年～2028年)
  • 主要地區的市場規模:各用途
    • 北美的粘膜下注射劑的銷售:各用途 (2017年～2022年)
    • 歐洲的粘膜下注射劑的銷售:各用途 (2017年～2022年)
    • 亞太地區的粘膜下注射劑的銷售:各用途 (2017年～2022年)
    • 南美的粘膜下注射劑的銷售:各用途 (2017年～2022年)
    • 中東、非洲的粘膜下注射劑的銷售:各用途 (2017年～2022年)

第5章 北美的粘膜下注射劑:各國

  • 過去的市場規模:各國
  • 市場規模的預測:各國

第6章 歐洲的粘膜下注射劑:各國

第7章 亞太地區的粘膜下注射劑:各地區

第8章 南美的粘膜下注射劑:各國

第9章 中東、非洲的粘膜下注射劑:各國

第10章 企業簡介:粘膜下注射劑事業的主要指標

  • SEIKAGAKU
  • OVESCO ENDOSCOPY
  • GI SUPPLY
  • COSMO PHARMACEUTICALS
  • BOSTON SCIENTIFIC
  • THE STANDARD
  • MICRO-TECH ENDOSCOPY
  • ENDOCLOT PLUS

第11章 上游工程、機會、課題、風險、影響要素的分析

  • 粘膜下注射劑的主要原料
  • 製造成本結構
  • 粘膜下注射劑的產業鏈的分析
  • 粘膜下注射劑的市場動態

第12章 行銷策略分析，經銷商

  • 銷售頻道
  • 粘膜下注射劑的經銷商
  • 粘膜下注射劑的下游工程客戶

第13章 調查結果結論

第14章 附錄

Market Analysis and Insights:

Due to the COVID-19 pandemic, the global Submucosal Injection Agent market size was value at US$ 95.35 million in 2021 and is forecast to be a readjusted size of US$ 159.76 million by 2028 with a CAGR of 7.65% during the forecast period 2022-2028.

Scope and Market Size:

The global Submucosal Injection Agent market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Submucosal Injection Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

By Company

  • Seikagaku
  • Ovesco Endoscopy
  • GI Supply
  • Cosmo Pharmaceuticals
  • Boston Scientific
  • The Standard
  • Micro-Tech Endoscopy
  • EndoClot Plus

Segment by Packaging Type

  • Syringe Type
  • Ampoule Type

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Rest of Europe
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Rest of Latin America
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 SUBMUCOSAL INJECTION AGENT MARKET OVERVIEW

  • 1.1 SUBMUCOSAL INJECTION AGENT PRODUCT OVERVIEW
  • 1.2 SUBMUCOSAL INJECTION AGENT MARKET SEGMENT BY TYPE
    • 1.2.1 SYRINGE TYPE
    • 1.2.2 AMPOULE TYPE
  • 1.3 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE BY TYPE
    • 1.3.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE OVERVIEW BY TYPE (2017-2028)
    • 1.3.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
    • 1.3.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY TYPE (2023-2028)
  • 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
    • 1.4.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.3 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.4 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.5 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)

2 SUBMUCOSAL INJECTION AGENT MARKET COMPETITION BY COMPANY

  • 2.1 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT SALES (2020-2022)
  • 2.2 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT REVENUE (2020-2022)
  • 2.3 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT PRICE (2020-2022)
  • 2.4 GLOBAL TOP MANUFACTURERS SUBMUCOSAL INJECTION AGENT MANUFACTURING BASE DISTRIBUTION, SALES AREA
  • 2.5 SUBMUCOSAL INJECTION AGENT MARKET COMPETITIVE SITUATION AND TRENDS
    • 2.5.1 SUBMUCOSAL INJECTION AGENT MARKET CONCENTRATION RATE (2020-2022)
    • 2.5.2 GLOBAL 3 AND 5 LARGEST MANUFACTURERS BY SUBMUCOSAL INJECTION AGENT REVENUE IN 2021
  • 2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN SUBMUCOSAL INJECTION AGENT AS OF 2021)
  • 2.7 KEY MANUFACTURERS SUBMUCOSAL INJECTION AGENT PRODUCT OFFERED

3 SUBMUCOSAL INJECTION AGENT STATUS AND OUTLOOK BY REGION

  • 3.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028
  • 3.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY REGION
    • 3.2.1 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2017-2022)
    • 3.2.2 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2017-2022)
    • 3.2.3 GLOBAL SUBMUCOSAL INJECTION AGENT SALES (VOLUME & VALUE), PRICE (2017-2022)
  • 3.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY REGION
    • 3.3.1 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2023-2028)
    • 3.3.2 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2023-2028)
    • 3.3.3 GLOBAL SUBMUCOSAL INJECTION AGENT SALES (VOLUME & VALUE), PRICE (2023-2028)

4 SUBMUCOSAL INJECTION AGENT BY APPLICATION

  • 4.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE BY APPLICATION
    • 4.1.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
    • 4.1.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
    • 4.1.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
  • 4.2 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
    • 4.2.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.3 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.4 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.5 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)

5 NORTH AMERICA SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 5.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 5.1.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 5.1.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 5.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 5.2.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 5.2.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

6 EUROPE SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 6.1 EUROPE SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 6.1.1 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 6.1.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 6.2 EUROPE SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 6.2.1 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 6.2.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

7 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT BY REGION

  • 7.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY REGION
    • 7.1.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2017-2022)
    • 7.1.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2017-2022)
  • 7.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY REGION
    • 7.2.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2023-2028)
    • 7.2.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2023-2028)

8 LATIN AMERICA SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 8.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 8.1.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 8.1.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 8.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 8.2.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 8.2.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

9 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 9.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 9.1.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 9.1.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 9.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 9.2.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 9.2.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

10 COMPANY PROFILES AND KEY FIGURES IN SUBMUCOSAL INJECTION AGENT BUSINESS

  • 10.1 SEIKAGAKU
    • 10.1.1 SEIKAGAKU CORPORATION INFORMATION
    • 10.1.2 SEIKAGAKU INTRODUCTION AND BUSINESS OVERVIEW
    • 10.1.3 SEIKAGAKU SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.1.4 SEIKAGAKU SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.2 OVESCO ENDOSCOPY
    • 10.2.1 OVESCO ENDOSCOPY CORPORATION INFORMATION
    • 10.2.2 OVESCO ENDOSCOPY INTRODUCTION AND BUSINESS OVERVIEW
    • 10.2.3 OVESCO ENDOSCOPY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.2.4 OVESCO ENDOSCOPY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.3 GI SUPPLY
    • 10.3.1 GI SUPPLY CORPORATION INFORMATION
    • 10.3.2 GI SUPPLY INTRODUCTION AND BUSINESS OVERVIEW
    • 10.3.3 GI SUPPLY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.3.4 GI SUPPLY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.4 COSMO PHARMACEUTICALS
    • 10.4.1 COSMO PHARMACEUTICALS CORPORATION INFORMATION
    • 10.4.2 COSMO PHARMACEUTICALS INTRODUCTION AND BUSINESS OVERVIEW
    • 10.4.3 COSMO PHARMACEUTICALS SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.4.4 COSMO PHARMACEUTICALS SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.5 BOSTON SCIENTIFIC
    • 10.5.1 BOSTON SCIENTIFIC CORPORATION INFORMATION
    • 10.5.2 BOSTON SCIENTIFIC INTRODUCTION AND BUSINESS OVERVIEW
    • 10.5.3 BOSTON SCIENTIFIC SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.5.4 BOSTON SCIENTIFIC SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.6 THE STANDARD
    • 10.6.1 THE STANDARD CORPORATION INFORMATION
    • 10.6.2 THE STANDARD INTRODUCTION AND BUSINESS OVERVIEW
    • 10.6.3 THE STANDARD SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.6.4 THE STANDARD SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.7 MICRO-TECH ENDOSCOPY
    • 10.7.1 MICRO-TECH ENDOSCOPY CORPORATION INFORMATION
    • 10.7.2 MICRO-TECH ENDOSCOPY INTRODUCTION AND BUSINESS OVERVIEW
    • 10.7.3 MICRO-TECH ENDOSCOPY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.7.4 MICRO-TECH ENDOSCOPY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.8 ENDOCLOT PLUS
    • 10.8.1 ENDOCLOT PLUS CORPORATION INFORMATION
    • 10.8.2 ENDOCLOT PLUS INTRODUCTION AND BUSINESS OVERVIEW
    • 10.8.3 ENDOCLOT PLUS SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.8.4 ENDOCLOT PLUS SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 11.1 SUBMUCOSAL INJECTION AGENT KEY RAW MATERIALS
    • 11.1.1 KEY RAW MATERIALS
    • 11.1.2 RAW MATERIALS KEY SUPPLIERS
  • 11.2 MANUFACTURING COST STRUCTURE
    • 11.2.1 RAW MATERIALS
    • 11.2.2 LABOR COST
    • 11.2.3 MANUFACTURING EXPENSES
  • 11.3 SUBMUCOSAL INJECTION AGENT INDUSTRIAL CHAIN ANALYSIS
  • 11.4 SUBMUCOSAL INJECTION AGENT MARKET DYNAMICS
    • 11.4.1 SUBMUCOSAL INJECTION AGENT INDUSTRY TRENDS
    • 11.4.2 SUBMUCOSAL INJECTION AGENT MARKET DRIVERS
    • 11.4.3 SUBMUCOSAL INJECTION AGENT MARKET CHALLENGES

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 12.1 SALES CHANNEL
  • 12.2 SUBMUCOSAL INJECTION AGENT DISTRIBUTORS
  • 12.3 SUBMUCOSAL INJECTION AGENT DOWNSTREAM CUSTOMERS

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

  • 14.1 RESEARCH METHODOLOGY
    • 14.1.1 METHODOLOGY/RESEARCH APPROACH
    • 14.1.2 DATA SOURCE
  • 14.2 AUTHOR DETAILS
  • 14.3 DISCLAIMER

LIST OF TABLES

  • Table 1. Global Submucosal Injection Agent Sales by Type: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Global Submucosal Injection Agent Sales by Type (2017-2022) & (K Units)
  • Table 3. Global Submucosal Injection Agent Sales Market Share in Volume by Type (2017-2022)
  • Table 4. Global Submucosal Injection Agent Sales by Type (2017-2022) & (US$ Million)
  • Table 5. Global Submucosal Injection Agent Sales Market Share in Value by Type (2017-2022)
  • Table 6. Global Submucosal Injection Agent Price by Type (2017-2022) & (US$/Unit)
  • Table 7. Global Submucosal Injection Agent Sales by Type (2023-2028) & (K Units)
  • Table 8. Global Submucosal Injection Agent Sales Market Share in Volume by Type (2023-2028)
  • Table 9. Global Submucosal Injection Agent Sales by Type (2023-2028) & (US$ Million)
  • Table 10. Global Submucosal Injection Agent Sales Market Share in Value by Type (2023-2028)
  • Table 11. Global Submucosal Injection Agent Price by Type (2023-2028) & (US$/Unit)
  • Table 12. North America Submucosal Injection Agent Sales by Type (2017-2022) & (K Units)
  • Table 13. Europe Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 14. Asia-Pacific Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 15. Latin America Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 16. Middle East and Africa Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 17. Global Submucosal Injection Agent Sales by Company (2020-2022) & (K Units)
  • Table 18. Global Submucosal Injection Agent Sales Share by Company (2020-2022)
  • Table 19. Global Submucosal Injection Agent Revenue by Company (2020-2022) & (US$ Million)
  • Table 20. Global Submucosal Injection Agent Revenue Share by Company (2020-2022)
  • Table 21. Global Market Submucosal Injection Agent Price by Company (2020-2022) & (US$/Unit)
  • Table 22. Global Submucosal Injection Agent Top Manufacturers Manufacturing Base Distribution and Sales Area
  • Table 23. Global Submucosal Injection Agent Manufacturers Market Concentration Ratio (CR5)
  • Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Submucosal Injection Agent as of 2021)
  • Table 25. Key Manufacturers Submucosal Injection Agent Product Type
  • Table 26. Global Submucosal Injection Agent Market Size Comparison by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 27. Global Submucosal Injection Agent Sales by Region (2017-2022) & (K Units)
  • Table 28. Global Submucosal Injection Agent Sales Market Share in Volume by Region (2017-2022)
  • Table 29. Global Submucosal Injection Agent Sales by Region (2017-2022) & (US$ Million)
  • Table 30. Global Submucosal Injection Agent Sales Market Share in Value by Region (2017-2022)
  • Table 31. Global Submucosal Injection Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) (2017-2022)
  • Table 32. Global Submucosal Injection Agent Sales by Region (2023-2028) & (K Units)
  • Table 33. Global Submucosal Injection Agent Sales Market Share in Volume by Region (2023-2028)
  • Table 34. Global Submucosal Injection Agent Sales by Region (2023-2028) & (US$ Million)
  • Table 35. Global Submucosal Injection Agent Sales Market Share in Value by Region (2023-2028)
  • Table 36. Global Submucosal Injection Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) (2023-2028)
  • Table 37. Global Submucosal Injection Agent Sales by Application: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 38. Global Submucosal Injection Agent Sales by Application (2017-2022) & (K Units)
  • Table 39. Global Submucosal Injection Agent Sales Market Share in Volume by Application (2017-2022)
  • Table 40. Global Submucosal Injection Agent Sales by Application (2017-2022) & (US$ Million)
  • Table 41. Global Submucosal Injection Agent Sales Market Share in Value by Application (2017-2022)
  • Table 42. Global Submucosal Injection Agent Price by Application (2017-2022) & (US$/Unit)
  • Table 43. Global Submucosal Injection Agent Sales by Application (2023-2028) & (K Units)
  • Table 44. Global Submucosal Injection Agent Sales Market Share in Volume by Application (2023-2028)
  • Table 45. Global Submucosal Injection Agent Sales by Application (2023-2028) & (US$ Million)
  • Table 46. Global Submucosal Injection Agent Sales Market Share in Value by Application (2023-2028)
  • Table 47. Global Submucosal Injection Agent Price by Application (2023-2028) & (US$/Unit)
  • Table 48. North America Submucosal Injection Agent Sales by Application (2017-2022) & (K Units)
  • Table 49. Europe Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 50. Asia-Pacific Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 51. Latin America Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 52. Middle East and Africa Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 53. North America Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 54. North America Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 55. North America Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 56. North America Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 57. North America Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 58. North America Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 59. Europe Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 60. Europe Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 61. Europe Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 62. Europe Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 63. Europe Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 64. Europe Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 65. Asia-Pacific Submucosal Injection Agent Sales by Region (2017-2022) & (K Units)
  • Table 66. Asia-Pacific Submucosal Injection Agent Sales Market Share in Volume by Region (2017-2022)
  • Table 67. Asia-Pacific Submucosal Injection Agent Sales by Region (2017-2022) & (US$ Million)
  • Table 68. Asia-Pacific Submucosal Injection Agent Sales Market Share in Value by Region (2017-2022)
  • Table 69. Asia-Pacific Submucosal Injection Agent Sales by Region (2023-2028) & (K Units)
  • Table 70. Asia-Pacific Submucosal Injection Agent Sales by Region (2023-2028) & (US$ Million)
  • Table 71. Latin America Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 72. Latin America Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 73. Latin America Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 74. Latin America Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 75. Latin America Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 76. Latin America Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 77. Middle East and Africa Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 78. Middle East and Africa Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 79. Middle East and Africa Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 80. Middle East and Africa Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 81. Middle East and Africa Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 82. Middle East and Africa Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 83. Seikagaku Corporation Information
  • Table 84. Seikagaku Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 85. Seikagaku Submucosal Injection Agent Product
  • Table 86. Ovesco Endoscopy Corporation Information
  • Table 87. Ovesco Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 88. Ovesco Endoscopy Submucosal Injection Agent Product
  • Table 89. GI Supply Corporation Information
  • Table 90. GI Supply Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 91. GI Supply Submucosal Injection Agent Product
  • Table 92. Cosmo Pharmaceuticals Corporation Information
  • Table 93. Cosmo Pharmaceuticals Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 94. Cosmo Pharmaceuticals Submucosal Injection Agent Product
  • Table 95. Boston Scientific Corporation Information
  • Table 96. Boston Scientific Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 97. Boston Scientific Submucosal Injection Agent Product
  • Table 98. The Standard Corporation Information
  • Table 99. The Standard Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 100. The Standard Submucosal Injection Agent Product
  • Table 101. Micro-Tech Endoscopy Corporation Information
  • Table 102. Micro-Tech Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 103. Micro-Tech Endoscopy Submucosal Injection Agent Product
  • Table 104. EndoClot Plus Corporation Information
  • Table 105. EndoClot Plus Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 106. EndoClot Plus Submucosal Injection Agent Product
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Submucosal Injection Agent Market Trends
  • Table 109. Submucosal Injection Agent Market Challenges
  • Table 110. Submucosal Injection Agent Distributors List
  • Table 111. Submucosal Injection Agent Downstream Customers
  • Table 112. Research Programs/Design for This Report
  • Table 113. Key Data Information from Secondary Sources
  • Table 114. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Submucosal Injection Agent Product Picture
  • Figure 2. Global Submucosal Injection Agent Market Size, 2017 VS 2021 VS 2028 (US$ Million)
  • Figure 3. Global Submucosal Injection Agent Market Size Status and Outlook (2017-2028) & (US$ Million)
  • Figure 4. Global Submucosal Injection Agent Sales Status and Outlook (2017-2028) & (K Units)
  • Figure 5. Product Picture of Syringe Type
  • Figure 6. Global Syringe Type Sales YoY Growth (2017-2028) & (K Units)
  • Figure 7. Product Picture of Ampoule Type
  • Figure 8. Global Ampoule Type Sales YoY Growth (2017-2028) & (K Units)
  • Figure 9. Global Submucosal Injection Agent Market Share by Type in 2021 & 2028
  • Figure 10. North America Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 11. Europe Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 12. Asia-Pacific Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 13. Latin America Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 14. Middle East and Africa Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 15. The 3 Largest Manufacturers in the World: Market Share by Submucosal Injection Agent Revenue in 2021
  • Figure 16. The 5 Largest Manufacturers in the World: Market Share by Submucosal Injection Agent Revenue in 2021
  • Figure 17. Global Submucosal Injection Agent Market Share by Application in 2021
  • Figure 18. North America Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 19. Europe Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 20. Asia-Pacific Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 21. Latin America Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 22. Middle East and Africa Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 23. Submucosal Injection Agent Manufacturing Cost Structure
  • Figure 24. Submucosal Injection Agent Industrial Chain Analysis
  • Figure 25. Channels of Distribution
  • Figure 26. Distributors Profiles
  • Figure 27. Bottom-up and Top-down Approaches for This Report
  • Figure 28. Data Triangulation
  • Figure 29. Key Executives Interviewed 74